Company:  BROOKFIELD GLOBAL LISTED ... (INF)
Form Type:  497
Filing Date:  8/26/2011 
CIK:  0001522807 
Address:  THREE WORLD FINANCIAL CENTER,
200 VESEY STREET
 
City, State, Zip:  NEW YORK, New York 10281 
Telephone:  212-549-8328 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$23.32  
Change: 
0.00 (0.00%)  
Trade Time: 
May 24  
Market Cap: 
$180.85M
Register for a Free Trial and access this filing in:     
  FORM 497
    PORTFOLIO OF INVESTMENTS
    PORTFOLIO OF INVESTMENTS
    PORTFOLIO OF INVESTMENTS
    SHAREHOLDER FEES
    INVESTMENT OBJECTIVE AND POLICIES
    Investment Objective
    RISK FACTORS AND SPECIAL CONSIDERATIONS
    Risks Associated With Long-Term Objective; Not a Complete ...
    Potential Conflicts of Interest Risk-Allocation of ...
    Investment Companies/Exchange-Traded Funds Risk
    Risks Associated With Status as a Regulated Investment Company
    Investment Restrictions Risk
    MANAGEMENT OF THE FUND
    The Investment Adviser
    The Investment Sub-Adviser
    Portfolio Management
    Payment of Expenses
    DISTRIBUTIONS AND DIVIDENDS
    NET ASSET VALUE
    LIMITATION ON DIRECTORS' AND OFFICERS' LIABILITY
    ADDITIONAL INFORMATION
    STATEMENT OF ADDITIONAL INFORMATION
    This Statement of Additional Information is dated August 25, ...
      Additional Investment Policies
      MANAGEMENT OF THE FUND
      Directors and Officers
        NAME AND TITLE
        NAME AND TITLE
        NAME AND TITLE
      Additional Information Concerning Our Board of Directors
      Beneficial Ownership of Shares Held in the Fund and the ...
        TRUSTEE OWNERSHIP
      Remuneration of Directors and Officers
        COMPENSATION TABLE
      Investment Advisory and Administrative Arrangements
      Ownership of Securities
      DISTRIBUTIONS AND DIVIDENDS
      PORTFOLIO TRANSACTIONS
      Code of Ethics
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
          BALANCE SHEET
    APPENDIX A
    APPENDIX B
      Board of Directors
      Poison Pills-Management Proposals to Ratify a Pill to ...
      Pay for Performance